Detalhe da pesquisa
1.
Discovery and optimization of pyridyl-cycloalkyl-carboxylic acids as inhibitors of microsomal prostaglandin E synthase-1 for the treatment of endometriosis.
Bioorg Med Chem Lett
; 29(18): 2700-2705, 2019 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31362919
2.
Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069.
J Med Chem
; 65(21): 14843-14863, 2022 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36270630
3.
Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers.
Sci Rep
; 11(1): 19877, 2021 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34615939
4.
Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2A.
J Med Chem
; 64(21): 15883-15911, 2021 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34699202
5.
Discovery and Characterization of the Potent and Selective P2X4 Inhibitor N-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and Structure-Guided Amelioration of Its CYP3A4 Induction Profile.
J Med Chem
; 62(24): 11194-11217, 2019 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31746599
6.
Identification of a Benzimidazolecarboxylic Acid Derivative (BAY 1316957) as a Potent and Selective Human Prostaglandin E2 Receptor Subtype 4 (hEP4-R) Antagonist for the Treatment of Endometriosis.
J Med Chem
; 62(5): 2541-2563, 2019 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30707023
7.
Correction to "Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069".
J Med Chem
; 66(1): 1082, 2023 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36542814